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Abstract
Much effort has focused recently on determining the mechanisms that control the allele-specific expression of genes
subject to genomic imprinting, yet imprinting regulation is only one aspect of configuring appropriate expression of these
genes. Imprinting control mechanisms must interact with those regulating the tissue-specific expression pattern of each
imprinted gene in a cluster. Proper expression of the imprinted Delta-like 1 (Dlk1)-Maternally expressed gene 3 (Meg3) gene
pair is required for normal fetal development in mammals, yet the mechanisms that control tissue-specific expression of
these genes are unknown. We have used a combination of in vivo and in vitro expression assays to localize cis-regulatory
elements that may regulate Dlk1 expression in the mouse embryo. A bacterial artificial chromosome transgene
encompassing the Dlk1 gene and 77 kb of flanking sequence conferred expression in most endogenous Dlk1-expressing
tissues. In combination with previous transgenic data, these experiments localize the majority of Dlk1 cis-regulatory
elements to a 41 kb region upstream of the gene. Cross-species sequence conservation was used to further define potential
regulatory elements, several of which functioned as enhancers in a luciferase expression assay. Two of these elements were
able to drive expression of a lacZ reporter transgene in Dlk1-expressing tissues in the mouse embryo. The sequence
proximal to Dlk1 therefore contains at least two discrete regions that may regulate tissue-specificity of Dlk1 expression.
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Introduction
Multicellular organisms generate an enormous diversity of
distinct cell types during embryonic development by the spatial
and temporal regulation of gene expression. Much of this
regulation occurs at the level of transcription, where positive and
negative cis-regulatory elements are employed to achieve fine
control over expression. Enhancers and silencers are DNA
elements composed of binding sites for transcription factors that
interact in cis with promoter-bound proteins to control gene
expression, functioning to allow or prevent, respectively, interac-
tion with the promoter-proximal transcriptional machinery. Many
developmentally important genes are also regulated by genomic
imprinting, the parental-specific expression of the two alleles of an
autosomal gene [1]. Imprinted gene expression is controlled on
multiple levels by DNA CpG methylation, histone protein
modification, higher order chromatin packaging, and likely
additional unknown processes. These imprinting regulatory
mechanisms are believed to specify the on or off state of each
allele of an imprinted gene, with the pattern and levels of
expression of that gene determined by tissue-specific enhancers.
The imprinting regulatory machinery must therefore coordinate
with the transcriptional regulatory machinery, and understanding
the control of imprinted gene expression requires full knowledge of
both components.
The imprinted Dlk1-Meg3 locus on mouse chromosome 12
(human 14q32) contains maternally- and paternally-expressed
genes, of which Dlk1 and Dio3 are the only members to produce
unique protein products [2–4]. Dlk1 encodes a transmembrane
protein containing six epidermal growth factor-like motifs with
similarity to the Delta-Notch-Serrate family of signaling molecules
[5,6]. The full length Dlk1 protein is cleaved to produce
membrane-bound and secreted/soluble forms of the protein by
the tumor necrosis factor alpha converting enzyme (TACE) [7].
Conflicting data exist as to the roles of the membrane-bound and
soluble forms of the Dlk1 protein, which appear to play complex
and perhaps complementary roles in multiple differentiating cell
types [6,8,9,10]. Several studies have shown that Dlk1 can act as a
Notch antagonist, a role consistent with its lack of the conserved
DSL interaction domain found in other Notch ligands [11–14]. In
cultured cells, soluble Dlk1 has been shown to inhibit the ability of
Notch to transactivate target genes such as Hes1 [12,13].
Additionally, Dlk1 appears to activate the insulin/IGF-I signaling
pathway, leading to activation of the extracellular regulated
kinase/mitogen-activated protein kinase (ERK/MAPK), but may
also signal through non ERK-dependent mechanisms [15–17].
Dlk1-null mice display pre- and postnatal growth retardation,
partially penetrant neonatal lethality, malformation of the ribs and
sternum and altered lipid metabolism [18]. Overexpression of Dlk1
is also deleterious, as animals expressing a two-fold excess of Dlk1
showed overgrowth during embryogenesis and postnatal lethality
possibly due to feeding defects [19]. Animals expressing a three-
fold Dlk1 excess died during late gestation with severe edema,
skeletal defects and underdeveloped lungs. These opposing animal
models bear many similarities to the phenotype of human patients
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some 14, which results in a loss or increase of Dlk1 expression,
respectively [20].
Functionally, Dlk1 is best understood as a regulator of the
transition of preadipocyte cells to mature adipocytes, and it is
downregulated upon the onset of differentiation in cultured
preadipocyte cells and in differentiating mesenchymal stem cells
[6,21–23]. Dlk1 also plays a role in skeletal muscle development
and regeneration, and mice with a myoblast-specific deletion of
Dlk1 are smaller than normal, with decreased skeletal muscle mass
[24]. These animals also show impaired regeneration of adult
muscle after injury, when satellite cells must be stimulated first to
proliferate and then to differentiate into new and engrafting
myoblasts.
Dlk1 and Meg3 display complex patterns of tissue- and temporal-
specific regulation. Dlk1 is expressed in the placenta and many
embryonic tissues, and expression is generally concordant between
mouse and human. During development, Dlk1 is expressed in fetal
hepatocytes, lung epithelium, adrenal cortex, the chondroblasts of
the developing skeleton, developing skeletal myoblasts, the ventral
diencephalon and Rathke’s pouch, peripheral nerves prior to
myelination, bone marrow and the thymic epithelium [25–31]. In
the pancreas, Dlk1 is initially expressed in most cells of the
pancreatic rudiment, becoming restricted first to the differentiating
endocrine cells, and finally to the beta cells alone [32]. In the
extraembryonic tissues of the mouse, Dlk1 is expressed in the fetal
endothelium of the yolk sac and the placental labyrinth [27,33].
Dlk1 expression declines after birth, and in the adult becomes
restricted to the pancreatic beta cells, the pituitary somatotrophs,
the bone marrow, and the zona glomerulosa of the adrenal gland
[25,28,31,34,35]. Previous groups have identified general positive
and negative transcriptional elements within the Dlk1 promoter-
proximal region, but nothing is known about the distal elements
that govern the complex tissue- and temporal-specific expression
pattern of this gene [36–39].
Closely linked to Dlk1 is the maternally expressed Meg3 gene,
which produces a long noncoding RNA that may function as a
developmental regulator and/or tumor suppressor [2,3,40–42].
Meg3 is expressed in the preimplantation mouse embryo, and as
differentiation proceeds it is found in the developing pancreas, the
paraxial mesoderm and the resulting myoblasts, the ventral
diencephalon and Rathke’s pouch, and in the dorsal root ganglia,
spinal cord and forebrain [43,44]. In mouse extraembryonic tissue,
Meg3 is expressed in the yolk sac, the labyrinthine trophoblast, and
some labyrinth endothelial cells [33,43]. Comparison of Dlk1 and
Meg3 expression shows a complex pattern of both shared and
discrete cell type-specific expression. Both genes are strongly
expressed in the myotome and migrating myoblasts, for example,
and both are down-regulated in skeletal muscle postnatally
[27,33]. In the pituitary, however, Dlk1 and Meg3 show coordinate
expression in the infundibulum and Rathke’s pouch during
development, but Dlk1 subsequently becomes restricted to
somatotrope cells, while Meg3 is expressed only in gonadotropes
[27,33].
Bacterial artificial chromosome (BAC) transgenesis in the mouse
is often used to localize regulatory elements within the sequences
surrounding a genomic locus [45]. Large BAC transgenes can
recapitulate genomic imprinting as well as expression, making
them ideal for studying imprinted gene regulation. Previous work
from our laboratory showed that the Meg3 gene was expressed and
properly imprinted from the 28G5 BAC transgene that spans the
region from 3.5 kb upstream of Dlk1 to 69 kb downstream of
Meg3, however, Dlk1 was not expressed from this transgene [46].
Another group subsequently showed that Dlk1 is expressed in a
subset of its normal pattern from a BAC transgene carrying 49 kb
of sequence upstream of Dlk1 (Tg
Dlk1270), but not from a BAC
transgene carrying only 8 kb of upstream sequence (Tg
Dlk1231)
[19]. In the current study we use additional transgenic and in vitro
approaches to identify discrete regions of sequence proximal to
Dlk1 that contain cis-regulatory elements capable of directing Dlk1-
like expression in the mouse embryo.
Materials and Methods
Generation of 127H5 BAC Transgenic Mice
The 127H5 BAC clone was isolated from the CITB 129/Sv
mouse genomic library (Children’s Hospital Oakland Research
Institute). The clone was end-sequenced and found to span 84 kb,
from 41 kb upstream to 36 kb downstream of the Dlk1 gene. The
BAC clone was linearized at a unique ClaI site 10.5 kb upstream of
Dlk1, and injected into fertilized FVB/N embryos as described
previously [46]. The resulting offspring were genotyped by PCR
using the primers OL477, 59-GCTTGAGTATTCTA-
TAGTGTCA-39, and OL478, 59-CAACGCAATTAATGT-
GAGTTAG-39, which amplify a 170 bp fragment of the BAC
vector. Founder animals were bred to wild type FVB/N mice to
establish independent transgenic lines, and transgene copy number
was calculated by Southern blotting as described [46].
Expression and Imprinting Analysis
Dlk1 expression was analyzed by Northern blotting, and
imprinting analysis was performed using RT-PCR and direct
sequencing as described [2]. Embryos and placentae were
recovered between e12.5 and e14.5 and adult tissues were
obtained from 3–4 week old animals. Total RNA was purified
using LiCl-urea precipitation [47]. For Northern analysis, 10 mgo f
total RNA was separated on 1% formaldehyde agarose gels and
transferred to Hybond N+ membranes. Membranes were hybrid-
ized with Dlk1 and b-actin probes; the Dlk1 probe is a 735 bp
fragment corresponding to nucleotides 685 to 1420, and the b-actin
probe is a 1200 bp fragment spanning exons 3–7. Hybridization
was carried out using Express-Hyb (Clontech) overnight at 65
oC,
and the membrane was washed three times for 15 min at 50uC
with Northern wash I (26SSC and 0.05% SDS), and twice for
15 min at 50uC with Northern wash II (0.16SSC and 0.1% SDS).
The membrane was exposed to a phosphorimager screen or film
for analysis and Dlk1 signal intensity was normalized to b-actin
expression. A student’s two-tailed t-test was used to determine
statistical significance. For RT-PCR, 2 mg total RNA was reverse
transcribed using Superscript III (Invitrogen) and oligo-dT, RT
reactions were diluted 1:10 and 2 ml was used for all PCR analyses.
Identification and Cloning of Conserved Elements
Upstream of Dlk1
Sequence conservation was analyzed using the University of
California Santa Cruz Genome Browser (http://genome.ucsc.
edu/) to compare the genomes of Mus musculus (July 2007
assembly), Rattus norvegicus (Nov. 2004), Homo sapiens (Feb. 2009),
Pan troglodytes (Oct. 2010), Macaca mulatta (Jan. 2006), Pongo abelii
(July 2007), Callithrix jacchus (Mar. 2009), Otolemur garnettii (Dec.
2006), Canis familiaris (May 2005), Felis catus (Dec. 2008), Equus
caballus (Sept. 2007), Bos taurus (Oct. 2007), Dasypus novemcinctus
(May 2005) and Loxodonta africana (July 2009). Vista browser
(http://genome.lbl.gov/vista) was also used to align Mus musculus
(July 2007) and Homo sapiens (Feb. 2009) sequences downloaded
from Ensembl (http://ensenmbl.org). Nine elements upstream of
Dlk1 (CE1–CE9) were selected that contained $50 bp stretches of
DNA with $70% sequence homology. The Dlk1 promoter
Dlk1 Transcriptional Regulatory Elements
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and cloned into the XhoI site of the pGL3-B plasmid (Promega),
generating plasmid pGL3-Dlk1P. The conserved elements were
amplified by PCR from 127H5 DNA using primers listed in
Table 1; PCR conditions for all primers were 94uC, 30 sec, 60uC,
1 min and 72uC, 1 min, for 35 cycles. The PCR products were
cloned into pCRII-TOPO, then excised using EcoRI, blunt ended
and inserted into the SmaI site of pGL3-Dlk1P. These plasmids
were termed pGL3-CE, where CE stands for the conserved
element.
Cell Culture and Transfection
The C2C12 cells were maintained in high glucose Dulbecco’s
Modified Eagle Medium (DMEM) (Invitrogen) with 10% fetal
bovine serum (FBS) and 4 mM L-glutamine. NIH-3T3 cells were
maintained in high glucose DMEM with 10% calf serum and
4 mM L-glutamine. SVR cells were maintained in high-glucose
DMEM with 5% FBS and 4 mM L-glutamine. Y-1 cells were
maintained in F-12K medium (Invitrogen) with 15% horse serum,
2.5% FBS and 2 mM L-glutamine. All cell lines were obtained
from ATCC. All media contained 100 mg/ml penicillin/strepto-
mycin and the cells were maintained in a humidified incubator at
37uC with 5% CO2.
For transfection, C2C12, NIH-3T3 and SVR cells were plated
in 24-well plates at a density of 50,000 cells/well; Y-1 cells were
plated at a density of 150,000 cells/well. Cell lines were transfected
with 200 ml of serum-free media per well containing Transfast
reagent at a 1:1 ratio, 0.7 mg of the appropriate pGL3 DNA, and
0.3 mg of the pSV-bgal control vector. Growth media was replaced
after 1 hour, and the cells were lysed 48 hours post-transfection
with 150 mlo f1 6 Glo Lysis Buffer (Promega). Luciferase
production was assayed using a Clarity Microplate Luminometer
(Bio-Tek Instruments Inc.) by adding 50 ml of cell lysate to 50 mlo f
Steady-Glo Luciferase Assay Substrate (Promega). Expression of
lacZ as b-galactosidase activity was measured by incubating 50 ml
of cell lysate with 143 ml of Z-Buffer (0.06 M Na2HPO4, 0.04 M
NaH2PO4, 0.01 M KCl, 0.001 M MgSO4), 36 ml ONPG (4 mg/
ml in diH20) and 1 ml 2–mercaptoethanol reagent (Fisher
Scientific) at 37uC for 30 min. After incubation, 300 ml of diH2O
was added to the reactions and the absorbance was measured at
414 nm. Luciferase expression was normalized to b-galactosidase
activity for each well. A student’s two-tailed t-test was used to
determine statistical significance.
Generation of CE-lacZ Transgenic Mice
A 2.4 kb fragment containing two copies of the chicken b-globin
insulator, 59HS4 [49], was excised from plasmid pJC13-1 using
EcoRI and BamHI and cloned in duplicate into the BglII and HpaI
sites of the pSL1180 shuttle vector, generating plasmid pSL-I. An
XbaI site in pNASS-b was destroyed to allow subsequent cloning,
and the lacZ gene was excised from this plasmid using EcoRI and
HindIII and inserted into the EcoRV site of pSL-I, generating pSL-
IL. The Dlk1 promoter was excised from pGL3-Dlk1P using XhoI
and NheI and cloned into the NheI site of pSL-IL to generate pSL-
ILP. The CE4, CE8 and CE9 fragments were excised from
pCRII-TOPO using EcoRI and cloned into the XbaI site of pSL-
ILP to generate CE4-lacZ, CE8-lacZ and CE9-lacZ, respectively.
CE4-lacZ and CE8-lacZ were linearized using NcoI and SnaBI,
CE9-lacZ was linearized using BstBI and SnaBI, and all transgenes
were purified with QIAEX II (Qiagen). Linearized DNA was
injected into FVB/N embryos by the UIC Transgenic Production
Service, and the embryos implanted in pseudopregnant ICR
females. Embryos were collected at e13.5 and fixed in 4%
paraformaldehyde for 90 min on ice, washed 3 times at room
temperature (RT) for 30 min (2 mM MgCl2, 0.01% deoxycholic
acid, 0.02% NP-40 in 16PBS), and stained overnight in the dark
at RT (1 mg/ml X-gal, 5 mM potassium ferricyanide, 5 mM
potassium ferrocyanide, 2 mM MgCl2, 0.01% deoxycholic acid,
0.02% NP-40). The reaction was stopped by washing the embryos
3 times in 16PBS at RT. Embryos were genotyped from yolk sac
DNA using primers OL410, 59-GGGGACGACAGTAC-
GAAAAGGC-39, and OL411, 59-GTATCGGCCTCAGGAA-
GATCGC-39 to generate a 789 bp lacZ product. PCR conditions
were 94uC, 30 sec, 60uC, 1 min and 72uC, 1 min, for 35 cycles.
Transgenic embryos were embedded in paraffin, and 8-micron
sagittal sections were cut and counterstained with eosin. Low
power images were collected on a Leica MZFLIII dissecting
microscope using a Leica DFC320 camera. High power images
were collected on a Zeiss Axiovert 200 M microscope using a Zeiss
AxioCam MRc5 camera.
Results
Dlk1 is Expressed but not Imprinted from the BAC 127H5
Transgene
Previous work showed that Dlk1 was not expressed from the
28G5 transgene spanning the mouse Dlk1-Meg3 region, suggesting
that elements outside of this BAC are required for Dlk1 expression
(Fig. 1A) [46]. To expand the search for Dlk1 regulatory
sequences, transgenic mice were produced using the overlapping
BAC 127H5, which extends 41 kb upstream and 36 kb down-
stream of the mouse Dlk1 gene (Fig. 1A). The BAC was linearized
at a unique ClaI site at 210.5 kb relative to the Dlk1
transcriptional initiation site. While this places much of the
upstream sequence in a position downstream of Dlk1 in the
transgene, this is not likely to alter the function of tissue-specific
enhancers. Enhancers are by definition position- and orientation-
Table 1. Primers used to amplify Dlk1 upstream conserved
elements.
Conserved
element Primer name Primer sequence
CE1 OL1152 59-TTAAGGAGGAGAGCCACTCACTGT-39
OL1153 59-TCAGGCAAAGGCCAGAGACAGAAA-39
CE2 OL1154 59-CTGTTGCGATGTAACTAGGTGGGA-39
OL1155 59-AAAGGCCAAGGACACCAGATCAGA-39
CE3 OL1156 59-TGGTTTGCCCTGCCTTCCTAGTAT-39
OL1157 59-ATCTGAAGGGTGCCACAACTGTCT-39
CE4 OL1158 59-GCAGGGCTTCGTTCTTTCCATGTT-39
OL1159 59-TCCATACATGGCCGGATGTGGTTA-39
CE5 OL1101 59-TCATCACCCAGCAAGAAGACAGGT-39
OL1102 59-TCTGCTCAACCAGCCTAGCTTACT-39
CE6 OL1090 59-TAAGGCACTACAGCAAGGAAGCCA-39
OL1100 59-TCCTGGGCATCAAACATGACCACT-39
CE7 OL1093 59-ACCTGAGGACGCCATTTGACCATA-39
OL1094 59-GCTCGCCAGCCAGAAGTAGAATTT-39
CE8 OL1095 59-GCTCTGTGTGCAATCTGCTTTCCA-39
OL1096 59-CAATGCCTGCAGCTTACCACACTT-39
CE9 OL1097 59-CCACACAACCTTCACCCAACCATT-39
OL1098 59-TTACTGGCTAGGCTCACAGAGCAA-39
doi:10.1371/journal.pone.0036483.t001
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heterologous in vivo expression vectors. We have also shown that
enhancers directing tissue-specific expression of the linked Meg3
gene function appropriately even when located on a separate,
cointegrated DNA fragment [46].
Three founder animals were obtained that carried 8, 2, and 2
copies of the BAC (data not shown). Individual transgenic lines
were established by breeding to FVB/N mice, and Dlk1 expression
levels were analyzed in whole embryo at embryonic day 12.5
(e12.5). Since the Dlk1 gene is subject to genomic imprinting,
expression levels were assayed in heterozygous embryos after both
maternal and paternal transmission of the transgene. Dlk1
expression from two of the lines was equal to wild type littermates
by Northern blotting, suggesting that Dlk1 was not expressed from
these transgenes (data not shown). In our experience, the lack of
expression from two of the three lines is not unusual for transgenic
animals, in which integrated sequences may be silenced by virtue
of their integration site, concatenated structure or bacterially-
derived vector sequences. The third line, which carries 2 copies of
the BAC, showed a 1.8 and 2.5 fold increase in Dlk1 expression
upon maternal and paternal transmission of the transgene,
respectively (Fig. 1B). These data show that Dlk1 is expressed
from the transgene in this 127H5 line, but suggest that it is not
imprinted (Fig. 1B, D). Dlk1 is normally expressed in the mouse
placenta at e12.5, but none of the 127H5 lines showed increased
levels of Dlk1 in placenta when compared to wild type (Fig. 1C, D
and data not shown).
To more directly analyze imprinting of the 127H5 transgene,
we took advantage of a congenic mouse line (Cg12) that carries the
Dlk1-Meg3 region of chromosome 12 from Mus musculus castaneus
(C) on a Mus musculus domesticus (D) background [50]. The Cg12
mice allow the use of sequence polymorphisms between C and D
animals for imprinting analysis in F1 offspring. Analysis of embryos
derived from a cross between 127H5 mice carrying D alleles, and
Cg12 mice carrying C alleles, showed that both parental alleles
were expressed, and that Dlk1 is not imprinted on the 127H5
transgene (Fig. 1E).
To determine the tissue-specific profile of 127H5 Dlk1
expression, three-week old 127H5 mice were analyzed for Dlk1
mRNA levels in isolated adrenal gland, brain, pituitary gland and
skeletal muscle (Fig. 1F). A significant increase in Dlk1 expression
over wild type was observed by Northern blotting in the adrenal
and pituitary glands and skeletal muscle of 127H5 mice, but no
increase in Dlk1 expression was observed in brain (Fig. 1F). The
levels of 127H5-derived Dlk1 expression were independent of the
direction of parental transmission, consistent with the lack of
imprinting observed in the embryo (Fig. 1E). Levels of Dlk1 in
skeletal muscle were increased to a greater degree than those seen
in other tissues, indicating a strong skeletal muscle enhancer may
lie within 127H5, and/or that a silencer that modifies Dlk1
expression is not present on the BAC. Skeletal muscle Dlk1 levels
were also higher in animals inheriting the transgene paternally
than in those inheriting it maternally, despite the lack of overt
imprinting of the transgene as a whole. While the reason for this
expression difference is unclear, it is possible the transgene carries
some component of the imprinting machinery that, in isolation,
remains capable of driving increased paternal expression in certain
tissues or in highly-expressing tissues. These data suggest that
127H5 contains the tissue specific elements required for Dlk1
expression in some, but not all, sites of endogenous Dlk1
expression.
These results are consistent with work from da Rocha et al,
which showed that a BAC transgene carrying 49 kb of sequence
upstream of Dlk1 (extending 8 kb beyond the 59 end of 127H5)i s
active in many sites of endogenous Dlk1 expression, including
kidney, skeletal muscle and liver, but is not expressed in placenta
[19]. Similarly to the data shown here, the Dlk1 gene was not
imprinted in the context of this transgene.
Conserved Elements Upstream of Dlk1 Function as
Enhancers in Cell Culture
The data obtained from the 28G5 and 127H5 transgenes
suggest that elements located in the non-overlapping sequence
(23.5 to 241 kb upstream of Dlk1) are capable of directing gene
expression in multiple Dlk1-expressing tissues. The sequence
upstream of Dlk1 was analyzed for conserved regions across
species using the University of California Santa Cruz (UCSC)
Genome Browser (http://genome.ucsc.edu/) and the Vista
browser (http://genome.lbl.gov/vista) (Fig. 2 and data not shown).
The UCSC browser measures evolutionary conservation between
multiple vertebrate species using phastCons and phyloP. Vista uses a
combination of Shuffle-LAGAN global alignments and local
BLAT alignments to construct genome-wide pairwise DNA
alignments between two species. The UCSC Genome Browser
alignment shown in Figure 2 makes use of all currently available
genome sequence, and with one exception supports the original
alignments performed in 2006. The highly conserved region at
approximately 215 kb was not present in comparisons performed
when fewer species were available, and awaits future functional
analysis.
Nine conserved elements of approximately 1 kb (CE1–9), that
contained $50 bp stretches of DNA with $70% sequence
homology, were chosen for further analysis (Fig. 2 and data not
shown). A luciferase reporter assay was used to screen the CEs for
regulatory activity; CEs were cloned into a luciferase expression
vector driven by the Dlk1 promoter, generating plasmids pGL3-
CE1 through pGL3-CE9 (Fig. 3A). Established cell lines selected
from tissues that express the endogenous Dlk1 gene: NIH-3T3
(mouse embryonic fibroblast), C2C12 (mouse myoblast), SVR
(mouse pancreatic islet) and Y-1 (mouse adrenal tumor), were
transiently transfected with the plasmids pGL3-B, pGL3-C, pGL3-
Dlk1P, or the individual pGL3-CEs. Luciferase activity was
measured relative to that driven by the Dlk1 promoter alone,
and all values were normalized to a transfection control (Fig. 3B).
Multiple CEs functioned as enhancers in the luciferase assay, with
CE4, 5, 7 and 9 showing higher levels of luciferase expression in
C2C12 cells than in other cell types, suggesting that these elements
might contain muscle specific enhancers (Fig. 3B). CE8 directed
high levels of luciferase expression in multiple cell lines, suggesting
that CE8 contains multiple enhancers or an enhancer that can
function in multiple tissues (Fig. 3B). Expression plasmids carrying
CE1, 2, 3 and 6 produced little or no luciferase activity over the
Dlk1 promoter alone.
Conserved Elements can Direct lacZ Expression in vivo
As CE4, CE8 and CE9 conferred the highest level of enhancer
activity in the reporter assay, these three regions were selected for
in vivo analysis. Reporter transgenes were generated carrying each
conserved element, and the Dlk1 promoter, upstream of a lacZ
cassette (CE4-lacZ, CE8-lacZ, and CE9-lacZ), and the transgenes
were flanked by insulator elements to reduce position effects
(Fig. 4A) [49]. The transgenes were injected into FVB/N fertilized
eggs, and F0 embryos were collected at e13.5 for whole-mount
analysis of lacZ expression. A total of 51 embryos were obtained
from the CE4-lacZ injections, of which 5 carried the transgene and
4 showed lacZ expression. A total of 77 embryos were obtained
from the CE8-lacZ injections, of which 16 embryos carried the
transgene and 9 showed lacZ expression. A total of 45 embryos
Dlk1 Transcriptional Regulatory Elements
PLoS ONE | www.plosone.org 4 May 2012 | Volume 7 | Issue 5 | e36483Figure 1. Dlk1 is expressed but not imprinted from the 127H5 transgene. (A) Schematic of the Dlk1-Meg3 BAC clones used to generate
transgenic mice; the 28G5 transgene was described previously [46]. The 127H5 BAC was linearized at a unique ClaI site. (B, C) Representative Northern
blots for Dlk1 mRNA in midgestation wild type (WT) and heterozygous transgenic (Tg) embryo (B) and placenta (C), after paternal (127H5
Pat) and
maternal (127H5
Mat) inheritance. The mouse b-actin gene was used as a loading control. (D) Quantitative Northern data for blots shown in B & C;
expression is normalized to b-actin. Gray bars represent wild type samples and black bars represent 127H5 transgenic samples upon paternal
(127H5
Pat) or maternal (127H5
Mat) transmission in crosses to Cg12. (E) Direct sequencing assay for Dlk1 imprinting in wild type (WT) and heterozygous
transgenic (Tg) F1 embryos after paternal (127H5
Pat) and maternal (127H5
Mat) inheritance. D indicates wild type animals carrying only the M.
domesticus allele, while D6Co rC 6D indicates offspring of crosses to the Cg12 line carrying a M. castaneus allele, with the female genotype listed first.
(F) Quantitative Northern blot analysis for Dlk1 mRNA in 3–4 week old 127H5 tissues. Expression is normalized to b-actin, and each bar represents 8–
10 animals. Gray bars represent wild type samples and the black bars represent 127H5 transgenic samples upon paternal (Pat) or maternal (Mat)
transmission. In all figures asterisks indicate p#0.05.
doi:10.1371/journal.pone.0036483.g001
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transgene and 5 showed lacZ expression. Positively staining
embryos were embedded and sectioned for histological analysis.
The chicken b-globin insulators functioned well in this system,
as most embryos carrying a particular transgene showed similar
patterns of expression despite their unique integration sites. In
previous work from our laboratory, the b-globin insulators were
Figure 2. Sequence conservation in the Dlk1 upstream region. The sequence upstream of Dlk1 was analyzed for regions of conservation
across multiple species. The conserved elements chosen for further analysis are numbered CE1 to CE9. The region being displayed corresponds to the
July 2007 mouse genome assembly; assembly dates for other species are given in the Methods (adapted from the UCSC Genome Browser).
doi:10.1371/journal.pone.0036483.g002
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elements, and to confer no activity on their own (Steshina &
Schmidt, unpublished). A particular tissue was scored as positive
for lacZ expression only if it was found in 3 or more embryos for a
given transgene. Embryos inheriting the CE4-lacZ transgene
displayed lacZ expression in multiple regions of the musculoskeletal
system and in some neuronal tissues (Fig. 4) (Table 2). CE4-lacZ
expression was seen in the intercostal muscles, the epiphyses of the
ribs and the body wall muscles of the abdomen (Fig. 4B–D, F–H).
Expression was also found in the intrinsic muscles of the tongue
(Fig. 4I, K). The expression seen in the dorsal root ganglia was
present in the cell bodies as well as the axons (Fig. 4I, J). CE4-lacZ
expression was also seen in the cortical region of the thymus
(Fig. 4L, M).
Embryos inheriting the CE8-lacZ transgene showed expression
in the migrating skeletal muscle of the limbs (Fig. 5A–F), and in the
developing skeleton including the ribs, costosternal junctions,
intervertebral cartilage and vertebrae (Fig. 5B, C, G–K) (Table 2).
CE8-lacZ expression was also observed in a subset of neuronal and
neuroendocrine tissues, including the chromaffin cells of the
adrenal medulla (Fig. 5L, M), the dorsal root ganglia (Fig. 5N, O),
and the spinal cord (Fig. 5P, Q). No consistent pattern of
expression was seen among the CE9-lacZ embryos, and so this
element was not analyzed further. Overall, expression in the
musculoskeletal system predominated from both the CE4 and CE8
elements, consistent with the high-level expression seen in muscle
in the 127H5 transgenic mice, and the high C2C12 activity in the
luciferase expression system. The pattern of expression from the
CE4-lacZ and CE8-lacZ transgenes overlaps significantly with that
of the endogenous Dlk1 gene [27,33], suggesting Dlk1-specific cis-
regulatory elements are contained within CE4 and CE8. Despite
this significant muscle expression, not all developing muscle is
positive for lacZ, suggesting the presence of elements that direct
Dlk1 expression in a specific subset of muscle cells or at a specific
stage of muscle development.
Discussion
The 127H5 Transgene Recapitulates Endogenous Dlk1
Expression
Previous work from our laboratory showed that the mouse Meg3
gene was expressed in a subset of its endogenous pattern from the
28G5 transgene, and was imprinted in those tissues where it was
expressed [46]. Dlk1 was not expressed from 28G5 in any tissues,
Figure 3. Transcriptional activation by conserved elements is cell line-dependent. (A) Luciferase expression plasmids used to assay
enhancer function in cell culture. ‘‘Dlk1 Promoter’’ signifies the Dlk1 basal promoter and CE signifies the individual conserved elements tested.
Plasmid pGL3-B contains the promoterless luciferase gene, pGL3-Dlk1P contains the endogenous Dlk1 promoter upstream of luciferase and pGL3-C
contains the SV40 promoter/enhancer upstream of luciferase. (B) Enhancer activity observed in the NIH-3T3, C2C12, SVR and Y-1 cell lines. Expression
is normalized to pGL3-Dlk1P for each cell type; the results are presented as mean 6 SEM. P-values relative to pGL3-Dlk1P expression are indicated by
*, p#0.05; #,p #0.01 (n=3) (Student’s t-test).
doi:10.1371/journal.pone.0036483.g003
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PLoS ONE | www.plosone.org 7 May 2012 | Volume 7 | Issue 5 | e36483Figure 4. CE4-lacZ displays expression in a subset of Dlk1-expressing tissues. (A) Diagram of lacZ expression constructs used to produce
CE4-lacZ and CE8-lacZ transgenic embryos. The arrow represents the direction of transcription, and CE stands for conserved element 4 or 8. (B–D)
Ventral, dorsal and lateral views, respectively, of a representative whole mount transgenic embryo at e13.5. (E) Schematic representation of sagittal
section planes used in these images [64]. (F–M) Sagittal sections of embryos under low magnification (F, I, L) and high magnification (G, H, J, K, M). All
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are required for Dlk1 expression. Consistent with this idea, a
subsequent study showed that the Tg
Dlk1270 BAC transgene
containing 49 kb of sequence upstream of Dlk1 could direct Dlk1
expression in a subset of endogenous Dlk1-expressing tissues [19].
The more proximal 127H5 transgene described here expands and
refines this work, localizing multiple cis-regulatory elements that
may control Dlk1 in developing skeletal muscle, and in neuroen-
docrine tissues such as the pituitary and adrenal glands, to a 41 kb
region upstream of Dlk1 (Fig. 1). The similarities in expression
between the 127H5 and Tg
Dlk1270 BAC transgenes, and the lack of
expression from Tg
Dlk1231, suggest most upstream regulatory
elements lie within the 241 kb to 28 kb region.
Dlk1 is not imprinted in the context of the 127H5 transgene; this
was not surprising, as this transgene lacks both the intergenic and
Meg3 differentially methylated regions shown to be required for
proper imprinting of the Dlk1-Meg3 locus (Fig. 1E) [51–53]. In
addition to expression in the embryo, placental expression of Dlk1-
Meg3 is also of interest, as many imprinted genes appear to play
important roles in placental development and function [54]. Meg3
is expressed in the placenta from the 28G5 transgene, but Dlk1
does not show placental expression from any of the BAC
transgenes, indicating yet more distal control elements exist for
Dlk1 extraembryonic expression [46] (Fig. 1C, D). We showed
previously that 28G5 carries some Meg3 control elements, and
have now shown that 127H5 carries some Dlk1 control elements;
this gene pair therefore has a complex regulatory domain spanning
more than 200 kb of sequence.
Coordinate versus Independent Regulation of Dlk1 and
Meg3
Dlk1 and Meg3 demonstrate a significant degree of overlap in
tissue-specific expression during development, but within a single
tissue these two genes are often expressed in dynamic and unique
patterns in different cell types. Both genes are highly expressed in
developing skeletal muscle, and they are coexpressed in fetal
hepatocytes and in the early pancreas. During later pancreas
development, however, Meg3 expression is downregulated, while
Dlk1 retains high level expression but becomes restricted to the
insulin-producing beta cells. Both genes are expressed in the
developing pituitary gland, initially in the infundibulum that gives
rise to the posterior lobe, and in Rathke’s pouch that gives rise to
the anterior lobe. In adults, however, Dlk1 expression is restricted
to the anterior somatotrophs, while Meg3 is expressed primarily in
gonadotrophs [27,33]. Dlk1 is highly expressed in the lung, where
Meg3 is not expressed, and Meg3 exhibits widespread expression in
the central nervous system, while Dlk1 is localized to a few brain
regions where Meg3 is absent [33]. While other imprinted gene
pairs such as H19-Igf2 share common regulatory elements, the
limited overlap in cellular expression of Dlk1-Meg3 suggests that
the many of their cis-regulatory elements are unique to each gene.
Data from the 28G5 and 127H5 transgenes largely support this
hypothesis, with Meg3 enhancers within 28G5 failing to activate
Dlk1, while most Dlk1 enhancers lie within the nonoverlapping
region of 127H5. Interestingly, the CE4-lacZ and CE8-lacZ
transgenes directed expression in a subset of neuronal tissues
where Meg3, but not Dlk1, is expressed, including the dorsal root
ganglia (Fig. 4I–J, 5N–O) and the spinal cord (Fig. 5P–Q). Some
Meg3-specific enhancers may therefore lie upstream of Dlk1, but
are prevented in vivo from activating expression of Dlk1.
Dissecting the Dlk1 Upstream Region
Multi-species comparison of the Dlk1 upstream region not
surprisingly demonstrated stronger conservation among more
closely related mammalian species, and less conservation with non-
mammalian vertebrates (Fig. 2 and data not shown). Although the
long-standing dogma has been that key regulatory elements will
show deep evolutionary conservation, recent analyses have often
refuted this idea. While the recognition sites for some DNA
binding factors are well-conserved across species [55], many are
poorly conserved even within mammals, and less so in lower
vertebrates [56,57]. Genomic imprinting is a uniquely mammalian
phenomenon, however, and while Dlk1 is present in many non-
mammalian vertebrates, it is not imprinted in these species. For
genes subject to genomic imprinting, it is possible that constraint
against harmful loss of imprinting would drive stronger conserva-
tion within mammals.
Within the 41 kb Dlk1 upstream region of 127H5, five highly
conserved elements were able to function as enhancers in cell
culture assays (Fig. 3), and two of these elements (CE4 and CE8)
directed reproducible expression of a lacZ reporter transgene in a
subset of Dlk1-expressing tissues in the mouse embryo (Fig. 4, 5).
These data suggest that CE4 and CE8 contain cis-regulatory
elements that direct Dlk1 expression in vivo. CE4-lacZ and CE8-lacZ
were both expressed in regions of the developing skeletal muscle,
and the developing cartilage of the axial skeleton, particularly in
the ribs and intervertebral discs (Fig. 4, 5). These patterns resemble
sections are oriented with anterior on top and dorsal to the left. Expression was seen in (F–H) intercostal muscle, body wall muscle, and ribs; (I, J)
dorsal root ganglia; (I, K) intrinsic tongue muscle; (L, M) thymus. The embryo shown in (F) displays lacZ expression in the pituitary gland and
trigeminal ganglion, both sites of endogenous Dlk1 expression, but this pattern was not seen in other embryos carrying CE4-lacZ. Scale bars represent
100 mm.
doi:10.1371/journal.pone.0036483.g004
Table 2. Embryonic expression of CE4-lacZ, CE8-lacZ and
Dlk1.
Tissue/organ CE4-lacZ CE8-lacZ Dlk1
Tongue muscle + – +
Intercostal muscle + – +
Body wall muscle + – +
Limb muscle – ++
Intervertebral cartilage – ++
Ribs +++
Thymus + – +
Pituitary gland – – +
Adrenal gland – ++
Liver – – +
Pancreas – – +
Lung – – +
Spinal cord – + –
Dorsal root ganglia ++–
+ indicates expression; – indicates no expression.
doi:10.1371/journal.pone.0036483.t002
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PLoS ONE | www.plosone.org 10 May 2012 | Volume 7 | Issue 5 | e36483the high level expression of endogenous Dlk1 found in the
developing skeletal muscle and the ossifying skeleton [27,33].
Endogenous Dlk1 is also expressed at high levels in many
neuroendocrine cell types, including the pituitary somatotrophs,
the chromaffin cells of the adrenal medulla, and the beta cells of
the pancreas. The 127H5 transgene directed pituitary and adrenal
expression (pancreas was not analyzed), and CE8-lacZ expressed
lacZ in the chromaffin cells of the adrenal gland (Fig. 1, 5). Neither
CE4-lacZ nor CE8-lacZ conferred expression in the pituitary,
however, and no expression was seen from the lacZ transgenes in
the developing pancreas. As 127H5 did not fully recapitulate
endogenous Dlk1 expression, and the sum of CE4-lacZ and CE8-
lacZ did not fully recapitulate 127H5 expression, there remain Dlk1
regulatory elements to be identified both within the span of
127H5, and in sequences outside this region.
Multiple Elements Regulate Dlk1 Expression in
Developing Skeletal Muscle
In the late gestation embryo, Dlk1 is most strongly expressed in
developing skeletal muscle, but the gene is silenced in muscle
shortly after birth. Sheep carrying the naturally-occurring
Callipyge (Clpg) mutation fail to down-regulate Dlk1 in specific
muscle groups, resulting in increased skeletal muscle mass [58–61].
Clpg has been mapped to a point mutation in the Dlk1-Meg3
intergenic region that is proposed to function as a cis-acting
silencer in postnatal tissues [62]. In myoblasts, as in many other
developing tissues, Dlk1 may function to regulate the switch from a
proliferating, immature cell population to a differentiating, mature
one. In adult mice, Dlk1 is reactivated in regenerating skeletal
muscle, where it may be involved in satellite cell activation and/or
proliferation [24].
MyoD is a key regulator of skeletal muscle development, where
it transactivates muscle-specific genes through cis-acting E-box
elements [63]. The loss of Dlk1 in skeletal muscle-specific knockout
mice is associated with reduced MyoD expression, perhaps
through activation of the NF-kappa B pathway, providing support
for an interaction between Dlk1 and MyoD in skeletal muscle [24].
The CE4-lacZ and CE8-lacZ transgenes showed strong myoblast
expression (Fig. 4, 5), indicating that muscle-specific transcription
factors may recognize the CE4 and CE8 elements. This work
significantly narrows the regions to be investigated for possible
interaction with MyoD and other, yet unknown, regulators of Dlk1
tissue-expression in the mouse embryo.
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